Cargando…

Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594840/
https://www.ncbi.nlm.nih.gov/pubmed/31363309
http://dx.doi.org/10.18773/austprescr.2019.029
_version_ 1783430308850302976
collection PubMed
description
format Online
Article
Text
id pubmed-6594840
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-65948402019-07-30 Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease Aust Prescr New Drug NPS MedicineWise 2019-04-24 2019-06 /pmc/articles/PMC6594840/ /pubmed/31363309 http://dx.doi.org/10.18773/austprescr.2019.029 Text en (c) NPS MedicineWise 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drug
Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title_full Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title_fullStr Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title_full_unstemmed Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title_short Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
title_sort cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
topic New Drug
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594840/
https://www.ncbi.nlm.nih.gov/pubmed/31363309
http://dx.doi.org/10.18773/austprescr.2019.029